Equities Analysts Set Expectations for FibroGen Q1 Earnings
FibroGen, Inc. (NASDAQ:FGEN – Free Report) – Equities research analysts at William Blair issued their Q1 2025 earnings per share estimates for shares of FibroGen in a research report issued to clients and investors on Tuesday, March 18th. William Blair analyst A. Hsieh anticipates that the biopharmaceutical company will post earnings of $0.02 per share […]
FibroGen, Inc. (NASDAQ:FGEN – Free Report) – Equities research analysts at William Blair issued their Q1 2025 earnings per share estimates for shares of FibroGen in a research report issued to clients and investors on Tuesday, March 18th. William Blair analyst A. Hsieh anticipates that the biopharmaceutical company will post earnings of $0.02 per share […]
